ReviewApplied biochemistry and biotechnology2026
Effective Abatement of Multidrug-resistant Pathogens Employing Natural Polyphenols and Polyphenol-based Formulations: A Systematic Review and Integrated Network Pharmacology Approach.
Review in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The upsurge in multidrug-resistant (MDR) bacterial pathogens poses a dire global public health concern, limiting the effectiveness of conventional antibiotics. Natural polyphenols and their derivatives have attracted immense attention due to their versatile pharmacological potentials encompassing antimicrobial, anti-biofilm, and anti-quorum sensing activities. However, a comprehensive understanding of polyphenols combating MDR pathogens and the mechanistic interactions needs to be elucidated. This systematic review aimed to evaluate the effectiveness of natural polyphenols and polyphenol-based formulations against MDR bacterial pathogens, along with inherent molecular targets, using an integrated network pharmacology approach. A systematic literature search following PRISMA guidelines was conducted across PubMed, Google Scholar, and the Cochrane databases, including peer-reviewed publications from 2015 to 2025. Studies reporting polyphenolic compounds and derivatives against MDR bacteria were derived based on predefined inclusion and exclusion criteria. Seventeen studies (n = 17), including one clinical trial, met the inclusion criteria solely on polyphenolic compounds against MDR bacteria. Evidence indicates that natural polyphenols and their derivatives exert antimicrobial effects through multiple mechanisms, including efflux pump inhibition, quorum-sensing interference, biofilm disruption, and membrane damage. Further, nanoformulated polyphenols and metal-polyphenol complexes demonstrated enhanced stability, bioavailability, and synergistic activity with antibiotics for combating MDR pathogens. Network pharmacology analysis revealed significant interactions between polyphenols and virulence-related genes in Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus, highlighting their potential as multi-target anti-virulence agents. Thus, multi-target mechanisms, combined with antibiotic adjuvant potentials and nanodelivery approaches, envisage future translational research, clinical validation, and sustainable AMR therapies that align with global One Health initiatives and SDG 3.
Indexed as
Identifiers
42714708What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.